and species distribution of pathogens related to bloodstream infections documented on Aids patients, with special emphasis on fungemic episodes.
PATIENTS AND METHODS
During a 21 month-period we evaluated Aids inpatients at advanced stage of the disease who experimented more than 3 days of fever at any time during the hospitalization at 3 tertiary care hospitals from São Paulo, Brazil: Hospital e Maternidade Santa Marcelina, Hospital Heliópolis and Hospital São Paulo, Universidade Federal de São Paulo.
We selected all patients older than 13 years old, who had a febrile syndrome (temperature ≥ 38°C) and late stage of Aids confirmed by HIV serology and CD4+ T lymphocyte count ≤ 200 cells/ml. We excluded all patients who had the identification of the etiologic agent of the febrile syndrome before hospitalization. All enrolled patients had a pair of blood cultures collected at the admission and any time during the hospitalization if they developed unknown origin fever after the admission. The blood cultures were aseptically collected at no less than hourly intervals. A 10 ml blood sample from each culture collected was directly inoculated into isolator system vial (Wampole Laboratories, Cranbury, New Jersey, USA) and processed according to the manufacturer's instructions. In brief, the bottles were centrifuged for 30 min and aliquots of the obtained sediment were seeded in blood agar, chocolate agar, brain-heart infusion, Sabouraud dextrose agar and Löwenstein-Jensen culture media. The cultures were incubated at 35°C during a period of up to 45 days.
The investigator visited the selected patients once a week to report demographic and clinical data, as well as all laboratory results related to the investigation of the febrile episode. For each patient the following information was systematically collected: sex, age, risk factors for HIV infection, previous opportunistic infections, signs and symptoms of the infection, results of laboratory tests of interest to the case, use of antimicrobial agents, presence of a central venous catheter (CVC) and outcome.
The patients were followed from the admission up to discharge or death. It is important to note that except for the blood cultures that were systematically collected, all lab tests and other diagnostic procedures were only requested by individual decision of the assistant physician.
The bacteria isolates were identified by means of microscopical examination as well as biochemical tests. The mycobacteria were identified by their morphology on ZiehlNielsen stain, as well as by biochemical tests (NCCLS 1995) . Yeasts were identified based on their morphological characteristics and biochemical profile evaluated by the API 20C AUX disposable plastic galleries (BioMérieux SA, Marcy-l'Etoille, France). Filamentous and dimorphic fungi were identified according to the micromorphologic characteristics of the culture (Warren & Hazen 1995 , Hoog & Guarro 1995 .
The definition of BSI was based on that proposed by the Center of Disease Control, Atlanta, USA and it required that ≥ 1 culture of blood samples, which were obtained in the presence of fever (body temperature ≥ 38°C) not attributable to other causes, yielded bacteria or yeast (Garner et al. 1988) . Cases in which a single blood culture yielded coagulase-negative staphylococci, Corynebacterium species and Bacillus species were classified as "pseudo-bloodstream infections" (Reimer et al. 1997 , Kim et al. 2000 .
BSI were considered nosocomial if signs and symptoms became evident > 48 h after admission to the hospital or if the patient had been hospitalized 2 weeks before the current admission (Garner et al. 1988 ). All infections due to Mycobacterium, Cryptococcus neoformans and Histoplasma capsulatum were considered as community acquired infections.
RESULTS
We were able to evaluate 111 patients (68% male) with age ranging from 20 to 76 years (mean 36 years), exhibiting a CD4+ count between 1 and 200 (mean 64 cells). Patient's risk factors for HIV infection were as follows: non-drug users heterosexual patients (48%), intravenous drug users (20%), homossexuals (7%), bissexuals (3%), and unknown risk group (22%).
Almost 70% of the population was under highly active antiretroviral therapy (HAART) or other regimens of antiretroviral therapy at the time they were first evaluated. Only 14% of the patients presented, at any time during the study, a total granulocytes count of < 1000 cells/ml. We found that 40% of the patients had an indwelling medical device in place at the time they were sampled and 68% of them had already been exposed to previous antibiotic therapy. The main causes of hospitalization were: fever of unknown origin 28%, pneumonia 25%, neurologic syndromes 24%, hepatoesplenic febrile syndrome 17% and chronic diarrhea 6%.
A total of 54 out 111 evaluated patients exhibited positive blood cultures during the study, including 46 episodes considered as truly BSI and 8 judged as contamination. The distribution of pathogens related to BSI was as follows: 43% of episodes were caused by gram-positive bacteria, 20% by fungi, 15% by gram-negative, 15% by Mycobacterium spp. and 7% were caused for mixed flora (Table) . The rate of BSI in our population was 41%, including 17 (37%) episodes of community-acquired and 29 (63%) of nosocomial-acquired infections.
The most common etiological agents of BSI were: Staphylococcus aureus (41%), M. tuberculosis (13%), P. mirabilis, C. neoformans, H. capsulatum and C. albicans (7% each), P. aeruginosa (4%), coagulase-negative staphylococci, A. baumanii, S. marcescens and M. avium complex (2% each), and mixed flora episodes (6%).
The following agents represented community-acquired BSI: M. tuberculosis (7 episodes), S. aureus (4), C. neoformans (3), and H. capsulatum (3). Hospital-acquired BSI was represented by: S. aureus (15), C. albicans (3), P. mirabilis (3), P. aeruginosa (2), A. baumanii, coagulasenegative staphylococci and S. marcescens (1 each) and mixed flora infections (3).
Gram-positive bacteria were the etiologic agent responsible for 20 episodes of BSI, mostly represented by S. aureus hospital-acquired infections. It is noteworthy that 53% of them had a CVC in place at the time they were sampled and 66% of them were drug users. Patients with BSI for staphylococci exhibited CD4 + T lymphocyte count < 50 cells/ml in 66% of cases and a normal number of granulocytes.
Gram-negative bacteria were responsible for 7 episodes of hospital-acquired BSIs and P. mirabilis was the pathogen most commonly isolated. Gram-negative infections were mostly documented in patients who developed nosocomial pneumonia (57%). Patients with BSI for Gram-negative bacteria presented CD4+ T lymphocyte count < 50 cells/ml in 57% of cases and a normal number of granulocytes. C. albicans was responsible for 3 episodes of nosocomial acquired BSI and were documented in patients with more than 14 days of hospitalization and a CVC in place (100%) at the time they were sampled. Regarding laboratory tests, patients with candidemia presented CD4+ T lymphocyte count < 100 cells/ml and a normal number of granulocytes.
Cryptococcemia (3 cases) was documented in patients with a history of prolonged fever related to meningeal and/or pneumonic syndromes. Regarding to laboratory tests we should emphasize that all them had a normal number of granulocytes and CD4+ T lymphocyte count < 50 cells/ml.
H. capsulatum bloodstream infections (3 cases) were documented in patients with prolonged fever, hepatosplenomegaly and CD4+ T lymphocyte count < 50 cells/ml.
Mycobacterium spp. infections were found in 7 patients (15%) with a predominance of M. tuberculosis (6). Mycobacteremia was documented in patients with prolonged fever and hepatoesplenomegaly syndrome. Regarding laboratory tests, no patient presented granulocytopenia, and all them had CD4+ T lymphocyte count < 50 cells/ml.
The crude mortality rate of our patients was 39%, being 50% for patients with BSI and 31% for the others. Mortality rates of infections due to different pathogens were as follows: gram-negative bacteria (43%), gram-positive bacteria (45%), fungi (55.5%) and Mycobacterium spp. (86%). Mortality rates were 45% for hospital-acquired and 59% for community-acquired bloodstream infections.
DISCUSSION
In the present study we evaluated the prevalence of BSI in Aids patients with advanced stage of disease admitted to the hospital without diagnosis of the ongoing infection.
The main epidemiological characteristics of the Aids population included in this study was similar to that exhibited by most HIV patients in Brazil. We had a gender distribution of men 2:1 women and heterosexual transmission as the major risk factor for HIV infection.
We were able to identify 46 episodes (41%) of bloodstream infections in 111 patients. S. aureus was the pathogen most commonly associated with BSI in this study, responding for 41% of all episodes. Despite some authors have postulated that coagulase-negative staphylococci is the major agent of bacteremia in Aids patients, other investigators have found S. aureus as the predominant agent of BSI among gram-positive bacteremic episodes (Whimbey et al. 1986 , Jacobson et al. 1988 , Schaberg et al. 1991 , Banerjee et al. 1991 , Emori & Gaynes 1993 , Goetz et al. 1994 ). The ample presence of patients with a history of intravenous drug use in our population may, in part, explain the predominance of S. aureus among the BSI. The use intravenous drugs as well as S. aureus nasal carries are both factors that had been recognized as risk factors for S. aureus bacteremia among Aids patients (Tuazon & Sheagren 1974 , Ganesh et al. 1989 , Raviglione et al. 1990 ). Infections with gram-negative bacteria, the third cause of BSI in our patients, were related to pneumonia and neurological syndromes with reduced consciousness and necessity of mechanical ventilation. The etiologies of gramnegative BSI showed a predominance of Proteus mirabilis and Pseudomonas aeruginosa, pathogens commonly associated with nosocomial pneumonia in Brazilian institutions (Sader et al. 2001) . Regarding laboratory tests, this patient population presented CD4+ T lymphocyte counts < 50 cells/ml (70%) and absence of neutropenia with the supposedly primary infectious focus being nosocomial pneumonia. Gram-negative BSI in Aids patients have been commonly associated with diarrhea, including agents as Salmonella sp. and Shiguella sp. (Tumbarello et al. 1995 , Salavert Lleti et al. 1996 . The difference between our findings and the literature may be related with the diversity of Aids patients evaluated on different series. It is noteworthy that we excluded outpatients of this study and evaluated exclusively late-stage Aids patients who required hospitalization.
The infections with Mycobacterium spp. occurred in patients with prolonged fever, hepatosplenomegaly and disseminated lymphadenomegaly and all of them presented CD4+ T lymphocyte counts < 100 cells/ml. These findings are similar to those reported in other series, particularly in Latin America, where infections with Mycobacterium represent a significant public health problem. It should be pointed out that 6 of 7 Mycobacterium spp. were M. tuberculosis, confirming the higher prevalence of these species in causing opportunistic infections in patients with Aids in Brazil (Grynsztejn et al. 1997) .
Of the many Aids-associated infections, the invasive fungal infections are relatively common, especially in patients with a CD4+ T lymphocyte count of less than 200 cells/ml. Yeasts of the Candida and Cryptococcus genera are the most frequently identified fungi as cause of infection in these patients (Mess & Daar 1997) . In our patients, fungemia corresponded to 20% of the episodes of infection, with the following distribution: C. neoformans, H. capsulatum and C. albicans.
As expected, C. neoformans and H. capsulatum represented the majority of the documented episodes of fungemia in our series. Otherwise, we observed a high incidence of patients with candidemia, a complication reported in 7% of our cases. It should be mentioned that all these patients presented a long period of hospitalization and multiple risk factors for candidemia, including the presence of CVC, use of long-term parenteral alimentation, antibiotics, mucosal Candida infection and surgical procedures. These findings confirm previous observations in patients with HIV infection, where candidemia appears related to patients with advanced HIV disease and multiple risk factors for candidemia including invasive medical procedures, antibiotic use, as well as Candida colonization (Launay et al. 1998 , Tumbarello et al. 1999 .
After reviewing the English literature, we found 4 studies evaluating BSI in Aids patients (Whimbey et al. 1986 , Hickey & Shanson 1993 , Meyer et al. 1994 , Tumbarello et al. 1995 using different blood culture methods (BACTEC NR6A, COLORBACT, radiometric BACTEC 460), showing a variation of 35% to 73.4% in the proportion of BSI with gram-positive bacteria, 23.4% to 32.9% with gramnegative and 0.6 to 4.8% in candidemia. We did not find any study using systematically the isolator system in the investigation of systemic infections in patients with Aids. Data on BSI due to Candida sp. (7%) obtained in our series were higher than those mentioned before, but equivalent to the rate found in a study with systematic evaluation of infections by necropsy (10%) (Wilkes et al. 1988) . It is possible that the difference between the indices we found for candidemia and the previously published data is due to the fact that our evaluated patients were in worst clinical status and also to the better performance of the isolator in recognizing fungemia.
The design of the present study did not allow an accurate analysis of the isolator's performance related to other diagnostic methods. However, we may say that the isolator system contributed to the diagnosis of 41% of all episodes evaluated, including infections difficult to be diagnosis as candidemia, histoplasmosis and mycobacteremia. In conclusion BSI is a common complication of Aids patients with advanced stage of disease and is related with a high rate of mortality. Blood cultures performed by lysis-centrifugation method may be a useful tool for the diagnostic of opportunistic infections in Aids patients at advanced stage of disease.
